Judy M Coulson

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Venues

Cancers

Molecular cancer research : MCR

Oncogene

The Journal of pathology

University of Liverpool

University of London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Liverpool

United Kingdom

Professor :: Cellular and Molecular Physiology

University of Liverpool

United Kingdom

Reader :: Celluar and Molecular Physiology

University of Liverpool

United Kingdom

Senior Lecturer :: Cellular and Molecular Physiology

University of Liverpool

United Kingdom

Lecturer :: Physiology / Human Anatomy &Cell Biology

University of Nottingham

United Kingdom

PRDA II and Principle Investigator :: Clinical Oncology

University of Nottingham

United Kingdom

PDRA :: Clinical Oncology

Aston University

United Kingdom

PDRA :: Pharmaceutical and Biological Sciences

Education History

University of London

United Kingdom

PHD :: Charing Cross and Westminster Medical School

Publications

Sarah E Barnett, Jenna Kenyani, Martina Tripari, Zohra Butt, Rudi Grosman, Francesca Querques, Liam Shaw, Luisa C Silva, Zoe Goate, Stefan John Marciniak, Doris M Rassl, Richard J Jackson, Lu-Yun Lian, Peter W Szlosarek, Joseph J Sacco, Judy M Coulson
BAP1 loss is associated with higher ASS1 expression in epithelioid mesothelioma: implications for therapeutic stratification. Molecular cancer research : MCR (2023)
Sarah E Barnett, Jenna Kenyani, Martina Tripari, Zohra Butt, Rudi Grosman, Francesca Querques, Liam Shaw, Luisa C Silva, Zoe Goate, Stefan John Marciniak, Doris M Rassl, Richard J Jackson, Lu-Yun Lian, Peter W Szlosarek, Joseph J Sacco, Judy M Coulson
BAP1 loss is associated with higher ASS1 expression in epithelioid mesothelioma: implications for therapeutic stratification. Molecular cancer research : MCR (2023)
Sarah E Barnett, Anne Herrmann, Liam Shaw, Elisabeth N Gash, Harish Poptani, Joseph J Sacco, Judy M Coulson
The Chick Embryo Xenograft Model for Malignant Pleural Mesothelioma: A Cost and Time Efficient 3Rs Model for Drug Target Evaluation. Cancers 14 (23) (2022)
Sarah E Barnett, Anne Herrmann, Liam Shaw, Elisabeth N Gash, Harish Poptani, Joseph J Sacco, Judy M Coulson
The Chick Embryo Xenograft Model for Malignant Pleural Mesothelioma: A Cost and Time Efficient 3Rs Model for Drug Target Evaluation. Cancers 14 (23) (2022)
Dorota Sabat-Pośpiech, Kim Fabian-Kolpanowicz, Helen Kalirai, Natalie Kipling, Sarah E Coupland, Judy M Coulson, Andrew B Fielding
Aggressive uveal melanoma displays a high degree of centrosome amplification, opening the door to therapeutic intervention. The journal of pathology. Clinical research 8 (4) (2022)
Sarah E Barnett, Anne Herrmann, Liam Shaw, Elisabeth N Gash, Harish Poptani, Joseph J Sacco, Judy M Coulson
The Chick Embryo Xenograft Model for Malignant Pleural Mesothelioma: A Cost and Time Efficient 3Rs Model for Drug Target Evaluation. Cancers 14 (23) (2022)
Sarah E Barnett, Anne Herrmann, Liam Shaw, Elisabeth N Gash, Harish Poptani, Joseph J Sacco, Judy M Coulson
The Chick Embryo Xenograft Model for Malignant Pleural Mesothelioma: A Cost and Time Efficient 3Rs Model for Drug Target Evaluation. Cancers 14 (23) (2022)
Carlos R Figueiredo, Helen Kalirai, Joseph J Sacco, Ricardo A Azevedo, Andrew Duckworth, Joseph R Slupsky, Judy M Coulson, Sarah E Coupland
Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development. The Journal of pathology 250 (4) (2020)
Andrew B Fielding, Matthew Concannon, Sarah Darling, Emma V Rusilowicz-Jones, Joseph J Sacco, Ian A Prior, Michael J Clague, Sylvie Urbé, Judy M Coulson
The deubiquitylase USP15 regulates topoisomerase II alpha to maintain genome integrity. Oncogene 37 (17) (2018)

Judy M Coulson.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Judy M Coulson